Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Treprostinil by Liquidia Technologies for Pulmonary Hypertension: Likelihood of Approval
Treprostinil is under clinical development by Liquidia Technologies and currently in Pre-Registration for Pulmonary Hypertension. According to GlobalData, Pre-Registration drugs...
Data Insights
Treprostinil by United Therapeutics for Pulmonary Fibrosis: Likelihood of Approval
Treprostinil is under clinical development by United Therapeutics and currently in Phase III for Pulmonary Fibrosis. According to GlobalData, Phase...